Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the 3SBio’s SSGJ-707.

Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal ...

Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with nmHSPC, but only as a combination therapy.

Pfizer Inc. is conducting a study titled ‘Real-World Treatment Patterns and Clinical Effectiveness of Dacomitinib in Advanced Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor ...

Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced ...

New York City mayoral candidate Zohran Mamdani told business leaders that he would begin to discourage the use of the phrase ...

The International Chamber of Commerce (ICC), the world business organization representing more than 4.5-million-member ...

Pfizer (PFE) made some major changes to its diversity, equity, and inclusion (DEI) webpage on Thursday, joining other major American corporations that have recently aligned themselves closer with ...

SmallCap stocks can often be overlooked by institutional investors, yet they offer outsized return potential for those ...

JumpCloud Inc. sustains its ranking as a Top 100 Cybersecurity solution from Expert Insights. JumpCloud is a leading solution for user authentication, identity and access management, Zero Trust ...

The label expansion sought by GSK is a bid to compete with Pfizer and Moderna in the younger age groups of the RSV vaccine market. Pfizer’s Abrysvo and Moderna’s mRESVIA are both approved to prevent ...